Equillium Shares Are Trading Lower After the Company Announced Ono Pharmaceutical Has Made the Business Decision to Allow the Expiration of Its Option to Acquire Equillium's Rights to Itolizumab

BenzingaOct 31 09:02 ET

Ono Pharmaceutical Makes Strategic Business Decision to Allow Itolizumab Option to Expire

Dow JonesOct 31 07:00 ET

Ono Pharmaceutical: Revision of earnings forecasts and introduction of core-based performance

JPXOct 30 23:00 ET · Announcements

Ono Pharmaceutical: Interim Accounting Period Fiscal Period Ending March 2025 (April to September) Supplementary Financial Information (Consolidated IFRS)

JPXOct 30 23:00 ET · Announcements

Ono Pharmaceutical: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [IFRS] (consolidated)

JPXOct 30 23:00 ET · Announcements

Ono Pharmaceutical 1H Net Y41.64B Vs Net Y74.49B

Dow JonesOct 30 23:00 ET